In addition, it has been proposed that cytokines involved in the pathogenesis of psoriasis (e.g., TNF-α and IL-17) may also affect glucose metabolism, possibly promoting insulin resistance and thereby increasing the risk of CVD in these patients [45,46]. This evidence concerns the gene IL17A and psoriasis.